More specifically, the investigator will be able:
• To define and describe rhinosinusitis • To assess the management of rhinosinusitis in MBH • To come out with the prevalence of rhinosinusitis in MBH • To ascertain the standard management of rhinosinusitis The prevalence of AR is very high (>35%) among Nigerian Africans, and it is likely that environmental factors are responsible for major differences with other countries. Knowing the prevalence of Rhinosinusitis will serve as reference for many other investigations. This prevalence would tend to increase if the condition is not well managed at the level of the hospital. This is a cross sectional study in which data are collected from the hospital registers for patients having rhinosinusitis since 2011 till 2015. With these data, we aim at giving the prevalence of rhinosinusitis during this period. The study will also include 5 case studies met in the ENT department during the period of the study both on an in-patient and out-patient basis. We shall assess the demographic data, patient's history and management. The aim of these case studies is to have an in-depth idea on the management of rhinosinusitis in Mbingo Baptist Hospital compared to the already addressed international standards. Statistics of all cases of rhinosinusitis were taken from the ENT department registers from the year 2011 to 2015 (January to September). It is obvious that the prevalence of adult patients with rhinosinusitis is more than two times the prevalence of both the children and teenagers mixed. The total number of children from 2011 to 2015 was 677, teenagers were 514 and adults 3477, for a final total of 4668 people with rhinosinusitis. This may be due to the fact that adult patients have reinfections or relapsed conditions and therefore need to visit the hospital more frequently. This also may show their increase fragility and incapacity to control or to resist the allergens or causative agents. This information is better symbolized on figures 16, 17 and 18. For all of them the number of patients seen with rhinosinusitis was higher in 2014. From the table indicating the total prevalence of Rhinosinusitis from 2011 to 2015, it is showing that the prevalence of rhinosinusitis is lowest in 2015 with a percentage of 10.5% and highest in 2011

Introduction
Background and problem statement
It occurs worldwide and affects about 16% of the adult American population annually significantly impairing their quality of life. The direct costs associated with rhinosinusitis are higher than the background costs due to increased clinic visits and prescribed medications and the indirect costs due to inactivity days leading to reduced productivity are enormous. It has been found to be one of the Texila International Journal of Clinical Research Volume 3, Issue 2, Dec 2016 most costly physical conditions for American citizens with approximately $6 billion spent overall on its management Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are prevalent non communicable diseases increasing around the world, even in Africa. These chronic diseases confer a significant burden through direct or indirect symptoms, complications and cost. In contrast to developed countries, the government health program of many African countries focus only on transmissible diseases, malnutrition, maternal and infant mortality, while data on respiratory diseases remain scarce. The prevalence of AR is very high (>35%) among Nigerian Africans, and it is likely that environmental factors are responsible for major differences with other countries. AR prevalence is much higher in urban area, especially in capital cities from Africa. CRS is not less common. The advent of HIV-AIDS has further worsened the incidence of CRS in Africa. Local allergens related to African environmental settings are not well known. House dust mites and cockroaches are reported as major allergens in Africa, while pollen allergens remain poorly described. AR predisposes to development of other airway comorbidities such as allergic asthma, rhinosinusitis, nasal polyposis, adenoid hypertrophy and otitis media. Both AR and CRS significantly affect the quality of life of Africans through direct cost (payments to doctors for frequent consultations, prescribed medications, over the counter (OTC) drugs, alternative and complementary drugs), indirect costs (loss of work hours and school days) and intangible costs (loss of quality of life, pain and suffering, psychological maladjustment, social costs). These costs become significant in countries with high prevalence of allergy and low per capital income, as seen both in the Anglophone and Francophone African countries.
Thus the following research question of "what is the prevalence of rhinosinusitis?"
General objective
Our main objective is to assess the prevalence and management of rhinosinusitis in Mbingo Baptist Hospital.
Specific objective
More specifically, the investigator will be able:
• To define and describe rhinosinusitis • To assess the management of rhinosinusitis in MB • To come out with the prevalence of rhinosinusitis in MBH • To ascertain the standard management of rhinosinusitis
Hypothesis
Knowing the prevalence of Rhinosinusitis will serve as reference for many other investigations. This prevalence would tend to increase if the condition is not well managed at the level of the hospital.
Significance of the study
This study will go a long way to give information on the total number of rhinosinusitis cases from 2011 to 2015, in children, teenagers and adults. It will also go a long way to portray the management of rhinosinusitis with standardised protocols.
Scope of the study
This study is aimed at assessing the prevalence and management of rhinosinusitis in Mbingo Baptist Hospital, in children, teenagers and adults.
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Limitations
Financial and time constraints are the main limitations for this study. Without these the investigator would have worked in all the referral hospitals of the North West Region and why not in the whole Country.
Ethical statement
This study was approved by Texila American University. Since this was a retrospective study, informed written consent could not be obtained from the study participants. However, records of all participants were anonymised and de-identified for the purpose of such a study.
Conceptual model/ framework
This model illustrate the pattern through which rhinosinusitis occurs. It all start with a stimulating factors that could be found endogenously or exogenously. Once exposed to the allergens, the process starts by a response to the stimulant and the patient will react by excessive sneezing, nasal blockage, then post nasal drip, headache, facial pains and fever. There may be nasal polyps formation, with halitosis, hoarseness of voice, pharyngitis.
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Definition and characteristics
Rhinosinusitis denotes the concurrent inflammatory and infectious process affecting the nasal cavities and the contiguous paranasal sinuses resulting from the interaction of multiple host and environmental factors.
Rhinosinusitis, also known as a sinus infection or Sinusitis is inflammation of the sinuses resulting in symptoms. According to the official journal of American Academy of Otolaryngology-Head and Neck Surgery, Chronic sinusitis affects approximately 12.5% of people.
Sinusitis significantly impacts quality of life measures with decrements in general health perception, vitality and social functioning comparable with that observed in patients who have angina or chronic obstructive pulmonary disease. Sinusitis is one of the main reasons for which an antibiotic is prescribed and for lost productivity in the work force.
Children's sinuses are not fully developed until late in the teen years. Although small, the maxillary (behind the cheek) and ethmoid (between the eyes) sinuses are present at birth. Unlike in adults, paediatric sinusitis is difficult to diagnose because symptoms of sinusitis can be caused by other problems, such as viral illness and allergy. 
b. By severity of symptoms
All 5 guidelines recognize that an assessment of symptom severity is important to define the magnitude of disease and assist with treatment selection. For clinical purposes, the European Position Paper on Rhinosinusitis and Nasal Polyps 2007 and British Society for Allergy and Clinical Immunology guidelines categorize disease severity on the basis of a 10-cm visual analogue scale (VAS) that has been statistically validated for use in patients with RS. Patients responding to the question "How troublesome are your symptoms of rhinosinusitis?" provide a rating, with the scale ranging from 0 ("not troublesome") to 10 ("worst thinkable troublesome").
Scores are categorized as follows, between 0 and 3, mild disease; greater than 3 to 7, moderate disease; and greater than 7 to 10, severe disease. Scores greater than 5 have been correlated with quality of life detriments.
c. Acute rhinosinusitis
Acute sinusitis is usually precipitated by an earlier upper respiratory tract infection, generally of viral origin, mostly caused by rhinoviruses, coronaviruses, and influenza viruses, others caused by adenoviruses, human parainfluenza viruses, human respiratory syncytial virus, enteroviruses other than rhinoviruses, and metapneumovirus.
If the infection is of bacterial origin, the most common three causative agents are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Until recently, Haemophilus influenzae was the most common bacterial agent to cause sinus infections. However, introduction of the H. influenza type B (HIB) vaccine has dramatically decreased H. influenza type B infections and now non-typable H. influenza (NTHI) are predominantly seen in clinics. Other sinusitis-causing bacterial pathogens include Staphylococcus aureus and other streptococci species, anaerobic bacteria and, less commonly, gram negative bacteria.
Viral sinusitis typically lasts for 7 to 10 days, whereas bacterial sinusitis is more persistent. Approximately 0.5% to 2% of viral sinusitis results in subsequent bacterial sinusitis. It is thought that nasal irritation from nose blowing leads to the secondary bacterial infection.
Acute episodes of sinusitis can also result from fungal invasion. These infections are typically seen in patients with diabetes or other immune deficiencies (such as AIDS or transplant patients on immunosuppressive anti-rejection medications) and can be life-threatening. In type I diabetics, ketoacidosis can be associated with sinusitis due to muco-mycosis.
Chemical irritation can also trigger sinusitis, commonly from cigarette smoke and chlorine fumes. Rarely, it may be caused by a tooth infection. (Leung RS, Katial R (March 2008). "The diagnosis and management of acute and chronic sinusitis". Primary care). This will lead to what is called allergic rhinitis.
According to the American Academy of Family Physician, Acute rhinosinusitis has a relatively rapid onset, is normally of four weeks' duration or less and symptoms totally resolve. Most cases are viral in origin. Resolution of symptoms usually occurs within five to seven days, and most patients recover without medical intervention. The subcategory of acute bacterial rhinosinusitis is more likely to evolve into chronic disease or to spread outside the sinuses to the orbital area or to the meninges. Acute bacterial rhinosinusitis is suggested by symptoms including purulent drainage that worsens after five days or persists beyond 10 days, and/or symptoms that are out of proportion to those typically associated with a viral upper respiratory process.6 Recurrent acute rhinosinusitis is defined as four or more episodes of acute disease within a 12-month period, with resolution of symptoms between each episode (each episode of at least seven days' duration). Sub-acute rhinosinusitis is basically a low-grade continuum of acute infection of more than four weeks' but less than 12 weeks' duration. Chronic rhinosinusitis is distinguished by symptoms that persist for 12 weeks or more.
Young children are more prone to infections of the nose, sinus, and ears, especially in the first several years of life. These are most frequently caused by viral infections (colds), and they may be aggravated by allergies. However, if the child remains ill beyond the usual week to ten days, a sinus infection may be the cause.
• Allergic and non-allergic rhinitis i.
Allergic Rhinitis occurs when the body's immune system over-responds to specific, noninfectious particles such as plant pollens, molds, dust mites, animal hair, industrial chemicals (including tobacco smoke), foods, medicines, and insect venom. During an allergic attack, antibodies, primarily immunoglobin E (IgE), attach to mast cells (cells that release histamine) in the lungs, skin, and mucous membranes. Once IgE connects with the mast cells, a number of chemicals are released. One of the chemicals, histamine, opens the blood vessels and causes skin redness and swollen membranes. When this occurs in the nose, sneezing and congestion are the result.
Seasonal allergic rhinitis or hay fever occurs in late summer or spring. Hypersensitivity to ragweed, not hay, is the primary cause of seasonal allergic rhinitis in 75 percent of all Americans who suffer from this seasonal disorder. People with sensitivity to tree pollen have symptoms in late March or early April; an allergic reaction to mold spores occurs in October and November as a consequence of falling leaves.
Perennial allergic rhinitis occurs year-round and can result from sensitivity to pet hair, mold on wallpaper, houseplants, carpeting, and upholstery. Some studies suggest that air pollution such as automobile engine emissions can aggravate allergic rhinitis. Although bacteria is not the cause of allergic rhinitis, one medical study found a significant number of the bacteria Staphylococcus aureus
in the nasal passages of patients with year-round allergic rhinitis, concluding that the allergic condition may lead to higher bacterial levels, thereby creating a condition that worsens the allergies.
Patients who suffer from recurring bouts of allergic rhinitis should observe their symptoms on a continuous basis. If facial pain or a greenish-yellow nasal discharge occurs, a qualified ear, nose, and throat specialist can provide appropriate sinusitis treatment.
ii. Non-Allergic Rhinitis does not depend on the presence of IgE and is not due to an allergic reaction. The symptoms can be triggered by cigarette smoke and other pollutants as well as strong odors, alcoholic beverages, and cold. Other causes may include blockages in the nose, a deviated septum, infections, and over-use of medications such as decongestants
d. Chronic rhinosinusitis (CRS)
Chronic rhinosinusitis (CRS) is a complex disease associated with inflammation of nasal and sinus tissue. Currently, the cause of CRS remains unclear but researchers have proposed several mechanisms. In healthy people, the nose and sinuses are lined with epithelial cells and other specialized cells that form a mucosal barrier. This barrier serves to protect the underlying tissues from the millions of allergens, microbes, and particulates inhaled regularly. Such inhaled particles can be trapped in mucus and cleared through the action of cilia on nasal epithelial cells that move mucus out of the airways. In CRS, the mucosal barrier can be defective. Epithelial cells do not function normally, leading to a weak and permeable barrier. This impaired barrier is exposed to more particles and does not repair itself as well as a healthy barrier. There is increased thick mucus production in CRS that cannot be easily cleared away by nasal epithelial cilia.
Some people with CRS have persistent growth of fungi or bacteria such as Staphylococcus aureus in their nose and sinuses.
In some cases, the organism does not cause significant damage to tissue. However, problems can occur if an immune response is mounted against the colonising organism or to the toxins it makes. This immune response can cause inflammation and damage to the sinus and nasal tissues and worsen CRS.
• Cardinal signs or symptoms Prolonged duration of rhinosinusitis (RS) symptoms (more than 8-12 weeks) is the primary reason to evaluate a patient for CRS. In this regard, it is important to distinguish CRS from recurrent ARS, the latter of which is typified by 2 to 4 isolated episodes of ARS per year, with complete resolution of symptoms between episodes. Such episodes should be treated like any other ARS event but also warrant further work-up to investigate potential underlying causes for the recurrence (e.g., AR, cystic fibrosis, immunologic deficiency, ciliary dyskinesia, anatomic abnormalities).
• Factors contributing to sinusitis chronicity A similar set of factors contributes to sinusitis chronicity, but in addition other aspects of the host immune microbial interaction play a key role.
• Ostial blockage
The importance of sinus ostial patency was eloquently stated by Senior and Kennedy: "Sinus health in any patient depends on mucous secretion of normal viscosity, volume, and composition; normal muco-ciliary flow to prevent mucous stasis and subsequent infection; and open sinus ostia to allow adequate drainage and aeration.
While defect of any of these elements can result in acute, recurrent acute or chronic sinusitis, ostial blockage is key in the cycle for the vast majority of sinusitis in asthmatic and nonasthmatic patients alike." The above statement applies to all sinuses, but the sinus ostia most commonly blocked are those that drain through the ostiomeatal unit (OMU). Hence the anterior ethmoid and maxillary sinuses are the most commonly affected sinus areas in both acute and chronic sinusitis. results from obstruction of their respective ostia, which collectively drain through the sphenoethmoidal recess. In chronic sinusitis inflammatory mucosal thickening often persists despite treatment with antibiotics. This further impedes normal mucociliary clearance and may directly obstruct sinus ostia.
• Delayed recovery of mucociliary function Mucostasis, hypoxia, microbial products, and chronic inflammation probably all contribute to diminished mucociliary function in chronic sinusitis. Studies are conflicting on whether chronic sinusitis is associated with a significant reduction in ciliary beat frequency, but a decrease in mucociliary clearance has been consistently demonstrated. Other contributing factors to slowing of clearance include changes in the viscoelastic properties of mucus, ciliary loss, and other ultrastructural signs of epithelial damage.
• Mucus "recirculation" and osteitis
Other factors contributing to sinusitis chronicity include mucus "recirculation" and osteitis. Recirculation of sinus mucus from the maxillary sinus has been described in some patients with an accessory sinus ostium. Secretions exit the sinus through the natural sinus ostium and enter the middle meatus. Some of the secretions then re-enter the maxillary sinus through the accessory ostium, usually located inferior to the OMU (ostiomeatal unit) on the lateral nasal wall. From experience, accessory ostia to the maxillary sinus are quite common (approximately 20% of cases). Osteitis has been described by histologic analysis of ethmoid bone removed from patients with chronic sinusitis. It may occur as a direct result of infection or as a result of sinus surgery with lack of mucosal preservation. The histologic findings include a marked acceleration in bone turnover with new bone formation, fibrosis, and the presence of inflammatory cells. It has been argued that these changes mimic osteomyelitis in the jaw and that osteitis may therefore represent a form of chronic osteomyelitis and a strong reason for disease recurrence despite surgery or antibiotic use.
• Microbial factors in persistence
Most studies have pointed to differences between acute and chronic sinusitis in terms of microbial pathogens. In acute sinusitis, the predominant organisms are Streptococcus pneumoniae, Hemophilus influenzae, and (in children) Moraxella catarrhalis.
In studies of chronic sinusitis the most common organisms identified were those described above plus Staphylococcus aureus, coagulase-negative Staphylococcus, and anaerobic bacteria. The relative pathogenicity of the organisms in sinusitis is unknown, with the greatest uncertainty surrounding the role of coagulase-negative Staphylococcus and anaerobes.
Insufficient attention has been given to the potential for emergence of antimicrobial resistance during antibiotic treatment for chronic sinusitis. As demonstrated in the study of Brook et al, Betalactamase-producing bacteria can emerge during antibiotic treatment during the transition from acute to chronic sinusitis. Another possibility is the emergence of intermediate-or high-level penicillin resistance during treatment. This type of resistance, resulting from alterations in penicillin-binding proteins, presently ranges from 28% to 44% for S pneumoniae isolates in various regions of the United States. There are very limited data on the prevalence of these isolates in chronic sinusitis, but it appears that isolation of penicillin-resistant pneumococci is most commonly seen in patients with recent use of two or more antibiotics. Many of these organisms also demonstrate multiple drug resistance.
• Inflammatory factors in sinusitis 
Diagnostic measures of RS (Rhinosinusitis)
Rhinosinusitis (RS) can generally be diagnosed adequately on the basis of clinical findings alone, without the use of special imaging techniques or other assessments. However, the consensus guidelines recognize particular situations in which special assessments may have a role.
Other means include:
• CT-computed tomography. It is good for cases before surgery and for evaluation of cases with recurrent RS. Also, the presence of nasal congestion or blockage, discoloredrhinorrhea or postnasal drip, facial pain or pressure, hyposmia or anosmia together with consistent pathologic findings during nasal endoscopy or on CT scan establishes the diagnosis • Magnetic resonance imaging (MRI) is overly sensitive to the transient mucosal changes associated with a normal nasal cycle.
• Nasal Endoscopy. Compared with anterior nasal examination, nasal endoscopy provides a better means of examining the middle meatus region and sphenoethmoidal recesses for the presence of purulence associated with RS.
• Nasal Culture. Nasal culture is not generally recommended for the routine work-up of uncomplicated ARS; • Sinus Puncture. Although rarely indicated for routine patient care, sinus puncture is the methodology considered the criterion standard for confirming bacterial pathogens within the maxillary sinuses.
Management of rhinosinusitis i. Topical intranasal corticosteroids (INS) and nasal douching are first-line treatment for RS.
Nasal douching clears the sino-nasal cavity from pathogens and pro-inflammatory mediators. INS targets the inflammatory response underlying nasal congestion, promote osteomeatal complex drainage and occasionally improve the sense of smell. Moreover, a significant reduction in polyp size in cases of CRS with NP (CRSwNP) has been reported. Based on clinical experience, systemic corticoids remain important for the treatment of CRSwNP, as they provide short-term symptom relief. Short term courses of oral corticosteroids are usually given two to three times yearly.
ii. Oral antibiotics together with topical corticosteroids have been proven to act synergistically, though antibiotics are reserved for the acute exacerbations of RS. Low-dose macrolides (erythromycin, clarithromycin, roxithromycin and azithromycin) are the most studied antibiotics for CRS treatment have been used as a long-term antibiotic treatment in CRS, while topical antibiotics remain an option for refractory cases where traditional topical steroids and oral antibiotics are ineffective. iii. Nasal irrigation (douching) is a safe, inexpensive method with beneficial effects such as improvement in mucous clearance, enhanced ciliary beat activity, removal of antigens, biofilms or inflammatory mediators. Intranasal decongestants like xylomethazoline improve sinus ventilation through nasal decongestion, though prolonged use may have an opposite effect resulting in rhinitis medicamentosa. iv. Antihistamine have a minimal beneficial in CRS patients with concomitant AR.
According to the GALEN study, approximately, 57% of patients with CRS report symptoms of allergic rhinitis (AR) as well. The correlation with asthma is stronger in those patients with both CRS and AR symptoms.
In the absence of AR, CRS has a positive correlation with a late onset asthma. To sum up, checking for allergy is advocated in CRS patients. v. Antileukotrienes (montelukast) might have a beneficialeffect in patients with NP (nasal polyp).
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Following the current evolution in phenotyping, more personalized treatments based on the underlying inflammation will most likely be considered in the future.
vi. Surgery
Systematic reviews of cohort studies, large outcomes studies consistently support the safety and efficacy of functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis (CRS) with nasal polyps
Methods
Description of the study area
Mbingo Baptist Hospital is the largest of six hospitals run by the Cameroon Baptist Convention Health Services (www.cbchealthservices.org). This referral hospital originally begun as a leprosy settlement in 1952. Currently, it is a 290-bed referral teaching facility providing high quality, affordable and accessible care to those in need, as an expression of Christian love and witness. The hospital is located at 4300 feet elevation in the Northwest Region of Cameroon, 37 km north of Bamenda, the regional capital. Patients are currently received from throughout Cameroon and some surrounding African countries. The hospital runs a 24 hours service (three shifts system) with an average of 72,000 outpatients seen annually. The hospital is staffed by 15 full time specialty-trained physicians, 20 resident physicians, and a support staff of 600. It has a security system to safeguard clients, staff, and their
The It is in the ENT department that all patients with ENT related issues are being handled. Our study will consist of assessing the prevalence of rhinosinusitis from the ENT department in Mbingo Baptist Hospital.
• The ENT department of mbingo baptist hospital
The ENT department in Mbingo Baptist Hospital started functioning around the year 2010 by an ENT surgeon, Cameroonian and trained in Kenya. There were a lot of challenges in the beginning as it was a new field and he needed to do everything on his own and then, he gradually "borrowed "some other nurses from various units to assist him in one or two things.
He later on decided to train ENT clinical officers to help in handling most of the clinical activities while he would be busy with surgical activities. With time these clinical officers could also assist him in the theatre activities.
The ENT department is a specialty department. This means that it is dealing with patients having ENT problems.
• Process to reach ENT department and admission process When a patient comes to the hospital having ENT issues, the normal process wants that the screener sees the patient first then refers to the OPD doctor when needing special attention. This doctor after his assessment will refer the patient to the ENT department for further assessment and proper management.
When the patient reaches the ENT department, he is being screened and if he needs to be admitted, the admission sheet is filled with the presenting complaints, history, physical examination, impression/diagnosis, orders. After this step, the patient will care and advance some money at the inpatient payment office, then go to the laboratory just near the in-patient payment office for primary lap investigations, then go to the admission room where the auxiliary nurses taking demographic Texila International Journal of Clinical Research Volume 3, Issue 2, Dec 2016 information from the patient and his caregiver(s). From here the patient can go to ward to which he is admitted depending on the condition, the age and the gender.
When the patient reaches the ward, he is admitted by nurse and orders are carried and signed and acted upon while the patient is being put in the bed.
Research design, methodology and ethical considerations
This is a cross sectional study in which data are collected from the hospital registers for patients having rhinosinusitis since 2011 till 2015 (January to September). With these data, we aim at giving the prevalence and management of rhinosinusitis during this period.
The study will also include 5 case studies met in the ENT department during the period of the study both on an in-patient and out-patient basis. We shall assess the demographic data, patient's history and management. The aim of these case studies is to have an in-depth idea on the management of rhinosinusitis in Mbingo Baptist Hospital compared to the already addressed international standards. Figure 15 . prevalence of rhinosinusitis 
Results
Recommendations
• Mbingo Baptist Hospital should include allergic test in the lab investigations. In Mbingo, they base themselves mostly on clinical histories and complaints from the patients. This test will help differentiate between allergic rhinitis and non-allergic rhinitis.
• Increased education of the population on the condition (rhinosinusitis), its causative agents, its complications, and preventive measures would go a long way to reduce its prevalence.
• There is a need to have a CT scan in the Hospital. All patients that need CT scan are referred to some other places (like in Bafoussam, Douala or Yaoundé) and sometimes out of Bamenda town, to have the CT done, when the scan in Bamenda town is broken.
• Further studies may demonstrate the reasons behind this increase in the prevalence of rhinosinusitis in adults more than in children and teenagers.
